Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
  • Page 1 of 370
  • 1 to 25 of 9248 records
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-415
HR+
Luminal
Baicalein
Lipoxygenase
Metabolism
10938.072
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.5611
MDA-MB-415
HR+
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
9664.049
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.7193
MDA-MB-415
HR+
Luminal
AS-252424
PI3K
PI3K
10938.153
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.4228
MDA-MB-361
HER2amp
Luminal
GW843682X
PLK
PLK
10643.139
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.6402
MDA-MB-361
HER2amp
Luminal
SB-3CT
MMP2/9
MMP
12379.168
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.4672
MDA-MB-175-VII
HR+
Luminal
Cetuximab
EGFR
ErbB
7884.018
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.6074
MCF 10A
NM
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7483.095
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
2.6732
LY2
HR+
Luminal
TCS PIM-1 1
Pim kinase
PIM
10816.148
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.7402
MDA-MB-134-VI
HR+
Luminal
Cetuximab
EGFR
ErbB
10077.026
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.3999
Hs 578T
TNBC
Basal B
Baicalein
Lipoxygenase
Metabolism
7472.072
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
1.2269
LY2
HR+
Luminal
TCS PIM-1 1
Pim kinase
PIM
12319.135
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.3806
Hs 578T
TNBC
Basal B
Cetuximab
EGFR
ErbB
7861.018
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.8485
HCC1569
HER2amp
Basal A
Cetuximab
EGFR
ErbB
7824.018
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
1.3115
LY2
HR+
Luminal
ZM-447439
AURK
AURK
10816.15
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.3031
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7794.018
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
1.6812
HCC1395
TNBC
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
9254.049
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.8730
LY2
HR+
Luminal
L-779450
BRAF
MAPK
10816.149
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.4545
BT-20
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
5902.095
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
1.0245
HCC1806
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7450.095
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
1.7844
Hs 578T
TNBC
Basal B
Erlotinib
EGFR
ErbB
7475.091
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
2.6839
Hs 578T
TNBC
Basal B
Erlotinib
EGFR
ErbB
7473.091
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
2.3297
BT-483
HR+
Luminal
Cetuximab
EGFR
ErbB
9186.026
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.5108
BT-20
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
5904.095
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.6537
MDA-MB-415
HR+
Luminal
Selumetinib
MEK
MAPK
10938.155
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.5336
LY2
HR+
Luminal
PS-1145
IKK
NFKB
7477.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.7891
  • Page 1 of 370
  • 1 to 25 of 9248 records